cor2ed
engage checkpoint medical linkedin twitter
bg

Impact of the IMbrave150 Trial: Evolving Standards of Care for Advanced HCC (Americas & Europe)

Impact of the IMbrave150 Trial: Evolving Standards of Care for Advanced HCC (Americas & Europe)

Prof. Dr. Peter R. Galle

View this summary of the April 2020 HCC Experts Round Table meeting (Americas & Europe) and download the accompanying educational slide set for more information.
Portrait of Peter R. Galle
Prof. Dr. Peter R. Galle

Hepatologist

University of Mainz

Germany

preview next

time Video | open 5 min

download resources

I agree that this educational programme:

Was valuable to me:

1/3

The HCC Experts Round Table (Americas & Europe) brought together international experts in hepatocellular carcinoma. This interdisciplinary group (oncology, hepatology, radiology, patient advocacy, and health economics) explored evolving standards of care for advanced first-line HCC, particularly in light of IMbrave150 phase III clinical trial data. Follow the link above to view the recent publication announcement from the HCC Experts Round Table.

Other programmes of interest